Press release
Injectable Drug Delivery Market is Projected to Grow at 8.4% CAGR to Top US$ 1,10,998.3 Million by 2034
Injectable Drug Delivery Market
The global injectable drug delivery market is projected to attain a valuation of US$ 49,446.0 million by 2024 and is anticipated to surge to US$ 110,998.3 million by 2034, with a projected Compound Annual Growth Rate (CAGR) of 8.4% from 2024 to 2034.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9498
The injectable drug delivery market is experiencing unprecedented growth, driven by remarkable advancements in drug delivery technology. Injectable drug delivery systems have emerged as a vital component of modern healthcare, offering precise, targeted delivery of therapeutics to patients. From biologics to small molecules, injectable drug delivery systems have revolutionized the treatment landscape across various medical specialties.
Advanced Drug Delivery Systems:
Advancements in drug delivery systems have paved the way for the development of sophisticated injectable formulations that enhance therapeutic efficacy while minimizing side effects. Novel delivery platforms, such as liposomes, nanoparticles, microparticles, and hydrogels, enable controlled release and sustained delivery of drugs, prolonging their therapeutic effect and reducing the frequency of administration. Additionally, targeted drug delivery systems equipped with ligands or antibodies can selectively deliver drugs to specific tissues or cells, maximizing therapeutic benefits while minimizing systemic toxicity.
Biodegradable and Bioresorbable Materials:
The emergence of biodegradable and bioresorbable materials has revolutionized injectable drug delivery, offering enhanced biocompatibility and reduced risk of adverse reactions. Polymers such as polylactic acid (PLA), polyglycolic acid (PGA), and polylactic-co-glycolic acid (PLGA) are widely used in the formulation of injectable implants and microparticles, providing controlled release of drugs over extended periods. These biodegradable materials degrade naturally in the body, eliminating the need for surgical removal and minimizing patient discomfort.
Smart Injectable Devices:
The integration of smart technologies into injectable devices has ushered in a new era of precision medicine. Smart injectable devices equipped with sensors, microchips, and connectivity features enable real-time monitoring of drug delivery parameters, such as dosage, administration frequency, and patient adherence. These devices empower healthcare providers to personalize treatment regimens, optimize drug dosing, and remotely track patient progress, ultimately improving therapeutic outcomes and patient satisfaction.
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
Becton
Pfizer Inc.
Teva Pharmaceuticals Industries Ltd.
Eli Lilly and Company
Baxter International, Inc.
Sandoz
Terumo
Schott AG
Gerresheimer
Ypsomed
Bespak
B. Braun Melsungen
๐๐๐๐ ๐๐จ๐ซ๐:https://www.factmr.com/report/injectable-drug-delivery-market ๏ปฟ
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
Key players in the injectable drug delivery market are primarily focused on developing parenteral injections and implants aimed at aiding patients in their treatment journeys. These leading providers are actively engaged in research and development endeavors to introduce innovative products, striving to maintain a competitive edge in the injectable drug delivery technology market. Additionally, strategic investments in mergers, acquisitions, and partnerships are commonly employed by competitors to bolster their market presence and expand their product portfolios.
Recent Advancements:
West forged a significant partnership with Corning Incorporated in January 2022, aimed at enhancing the delivery of pharmaceutical injectable drugs. This collaboration leverages Corning's Valor Glass technology to enhance injectable drug packaging and delivery systems, thereby improving patient safety and accessibility to life-saving medications.
Novo Nordisk A/S introduced Novopen 6 and Novopen Echo Plus, two smart insulin pens, to the United Kingdom and Ireland markets in 2022. These innovative devices offer enhanced convenience and functionality for individuals managing diabetes, exemplifying the company's commitment to advancing diabetes care.
Antares Pharma, Inc. announced a phase 1 study on ATRS-1902 for adrenal crisis rescue in September 2021. This program supports the use of a novel auto-injector platform that delivers liquid hydrocortisone, catering to adults and adolescents with acute adrenal insufficiency and addressing critical medical needs.
Becton, Dickinson, and Company introduced the BD Ultrasafe Plus 2.25 cc Passive Needle Guard in November 2021. This innovative device, when used with a Glass Prefillable Syringe, facilitates the administration of biological solutions with volumes up to 2 ml and viscosities up to 30 cP, enhancing patient safety and user experience.
Taltz (ixekizumab) injectable, approved by the FDA in August 2019, offers a treatment option for individuals with radiographic axial spondyloarthritis (r-axSpA) or active ankylosing spondylitis. This approval underscores the commitment of pharmaceutical companies to address unmet medical needs and provide effective therapies for patients suffering from debilitating conditions.
The injectable drug delivery market is undergoing a period of unprecedented growth, driven by advancements in drug delivery technology and expanding therapeutic applications. From biodegradable implants to smart injectable devices, innovative solutions are revolutionizing the way drugs are administered and managed. As the healthcare industry continues to prioritize precision medicine and personalized therapies, injectable drug delivery systems are poised to play an increasingly critical role in delivering safe, effective, and targeted treatments to patients worldwide.
๐๐จ๐ฉ ๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง ๐ญ๐ก๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ
Generic Injectables Market
https://www.factmr.com/report/4681/generic-injectables-market#:~:text=Fact.MR%20has%20predicted%20the,quality%20drugs%20across%20the%20globe.
Drug Delivery Systems Market
https://www.factmr.com/report/4768/drug-delivery-systems-market
Novel Drug Delivery Systems (NDDS) Market
https://www.factmr.com/report/novel-drug-delivery-systems-ndds-market
๐๐จ๐ง๐ญ๐๐๐ญ:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
๐๐๐จ๐ฎ๐ญ ๐ ๐๐๐ญ.๐๐
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Injectable Drug Delivery Market is Projected to Grow at 8.4% CAGR to Top US$ 1,10,998.3 Million by 2034 here
News-ID: 3386879 • Views: โฆ
More Releases from Fact.MR
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decodingโฆ
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke โฆ
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleanersโฆ
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offeringโฆ
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 โฆ
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhanceโฆ
More Releases for Injectable
Key Small Molecule Injectable Drugs Market Trend for 2025-2034: Small Molecule I โฆ
What Is the Future Outlook for the Small Molecule Injectable Drugs Market's Size and Growth Rate?
The small molecule injectable drugs market has grown rapidly in recent years. It will rise from $219.57 billion in 2024 to $248.2 billion in 2025, at a CAGR of 13.0%. The growth is attributed to the rising prevalence of chronic diseases, an aging population, government initiatives, increased healthcare spending, and improvements in manufacturing processes.
The smallโฆ
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcomingโฆ
Facial Injectable Market Size to Hit $7.5 Billion by 2028 | Facial Injectable In โฆ
According to our experience research team, Facial Injectable Market was valued at USD 4.4 Billion in 2021, and the global Facial Injectable industry is projected to reach a value of USD 7.5 Billion by 2028, at a CAGR of 9.4% during the forecast period 2022-2028
The report is focused on gaining various Facial Injectable market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the globalโฆ
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis.
The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables thatโฆ
Global Injectable Drug Delivery Devices Market | Global Injectable Drug Delivery โฆ
The injectable drug delivery devices market involves of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors. The market contains the sales of the Injectable devices that have been comprehensively utilized for several routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and several others to cure the medical conditions vacillating from cancer to autoimmune disorders. The injectable drug delivery devices utilized in hospitals, clinicsโฆ
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut โฆ
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms ofโฆ
